nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—CYP1A2—Estropipate—osteoporosis	0.0682	0.111	CbGbCtD
Ondansetron—CYP2C9—Estropipate—osteoporosis	0.0614	0.1	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0507	0.0828	CbGbCtD
Ondansetron—CYP3A7—Estradiol—osteoporosis	0.0507	0.0828	CbGbCtD
Ondansetron—CYP3A5—Estradiol—osteoporosis	0.038	0.0621	CbGbCtD
Ondansetron—CYP3A4—Estropipate—osteoporosis	0.0357	0.0583	CbGbCtD
Ondansetron—CYP3A4—Calcitriol—osteoporosis	0.0357	0.0583	CbGbCtD
Ondansetron—CYP1A2—Conjugated Estrogens—osteoporosis	0.0322	0.0526	CbGbCtD
Ondansetron—CYP2C9—Cholecalciferol—osteoporosis	0.0316	0.0517	CbGbCtD
Ondansetron—CYP2D6—Cholecalciferol—osteoporosis	0.0289	0.0472	CbGbCtD
Ondansetron—CYP3A4—Ergocalciferol—osteoporosis	0.0285	0.0466	CbGbCtD
Ondansetron—CYP1A2—Estradiol—osteoporosis	0.0283	0.0462	CbGbCtD
Ondansetron—CYP2C9—Estradiol—osteoporosis	0.0255	0.0416	CbGbCtD
Ondansetron—CYP3A4—Raloxifene—osteoporosis	0.0238	0.0389	CbGbCtD
Ondansetron—CYP3A4—Ethinyl Estradiol—osteoporosis	0.023	0.0376	CbGbCtD
Ondansetron—CYP3A4—Cholecalciferol—osteoporosis	0.0184	0.03	CbGbCtD
Ondansetron—CYP3A4—Conjugated Estrogens—osteoporosis	0.0169	0.0276	CbGbCtD
Ondansetron—CYP3A4—Estradiol—osteoporosis	0.0148	0.0242	CbGbCtD
Ondansetron—Abdominal pain—Alendronate—osteoporosis	0.000424	0.0013	CcSEcCtD
Ondansetron—Body temperature increased—Alendronate—osteoporosis	0.000424	0.0013	CcSEcCtD
Ondansetron—Shock—Risedronate—osteoporosis	0.000423	0.0013	CcSEcCtD
Ondansetron—Nervous system disorder—Risedronate—osteoporosis	0.000422	0.00129	CcSEcCtD
Ondansetron—Discomfort—Pamidronate—osteoporosis	0.000421	0.00129	CcSEcCtD
Ondansetron—Agitation—Zoledronate—osteoporosis	0.00042	0.00129	CcSEcCtD
Ondansetron—Angioedema—Zoledronate—osteoporosis	0.000418	0.00128	CcSEcCtD
Ondansetron—Skin disorder—Risedronate—osteoporosis	0.000418	0.00128	CcSEcCtD
Ondansetron—Gastrointestinal pain—Calcitriol—osteoporosis	0.000418	0.00128	CcSEcCtD
Ondansetron—Abdominal pain—Raloxifene—osteoporosis	0.000417	0.00128	CcSEcCtD
Ondansetron—Body temperature increased—Raloxifene—osteoporosis	0.000417	0.00128	CcSEcCtD
Ondansetron—Vision blurred—Conjugated Estrogens—osteoporosis	0.000415	0.00127	CcSEcCtD
Ondansetron—Urticaria—Ibandronate—osteoporosis	0.000415	0.00127	CcSEcCtD
Ondansetron—Malaise—Zoledronate—osteoporosis	0.000413	0.00127	CcSEcCtD
Ondansetron—Body temperature increased—Ibandronate—osteoporosis	0.000412	0.00127	CcSEcCtD
Ondansetron—Abdominal pain—Ibandronate—osteoporosis	0.000412	0.00127	CcSEcCtD
Ondansetron—Syncope—Zoledronate—osteoporosis	0.00041	0.00126	CcSEcCtD
Ondansetron—Anaphylactic shock—Pamidronate—osteoporosis	0.000409	0.00125	CcSEcCtD
Ondansetron—Haemoglobin—Estradiol—osteoporosis	0.000407	0.00125	CcSEcCtD
Ondansetron—Urticaria—Calcitriol—osteoporosis	0.000406	0.00124	CcSEcCtD
Ondansetron—Haemorrhage—Estradiol—osteoporosis	0.000405	0.00124	CcSEcCtD
Ondansetron—Palpitations—Zoledronate—osteoporosis	0.000404	0.00124	CcSEcCtD
Ondansetron—Abdominal pain—Calcitriol—osteoporosis	0.000404	0.00124	CcSEcCtD
Ondansetron—Body temperature increased—Calcitriol—osteoporosis	0.000404	0.00124	CcSEcCtD
Ondansetron—Angioedema—Conjugated Estrogens—osteoporosis	0.000403	0.00123	CcSEcCtD
Ondansetron—Shock—Pamidronate—osteoporosis	0.000402	0.00123	CcSEcCtD
Ondansetron—Loss of consciousness—Zoledronate—osteoporosis	0.000402	0.00123	CcSEcCtD
Ondansetron—Hypersensitivity—Estropipate—osteoporosis	0.000401	0.00123	CcSEcCtD
Ondansetron—Nervous system disorder—Pamidronate—osteoporosis	0.000401	0.00123	CcSEcCtD
Ondansetron—Vomiting—Etidronic acid—osteoporosis	0.0004	0.00123	CcSEcCtD
Ondansetron—Cough—Zoledronate—osteoporosis	0.000399	0.00122	CcSEcCtD
Ondansetron—Tachycardia—Pamidronate—osteoporosis	0.000399	0.00122	CcSEcCtD
Ondansetron—Rash—Etidronic acid—osteoporosis	0.000397	0.00122	CcSEcCtD
Ondansetron—Convulsion—Zoledronate—osteoporosis	0.000396	0.00122	CcSEcCtD
Ondansetron—Dermatitis—Etidronic acid—osteoporosis	0.000396	0.00122	CcSEcCtD
Ondansetron—Syncope—Conjugated Estrogens—osteoporosis	0.000395	0.00121	CcSEcCtD
Ondansetron—Hypersensitivity—Alendronate—osteoporosis	0.000395	0.00121	CcSEcCtD
Ondansetron—Headache—Etidronic acid—osteoporosis	0.000394	0.00121	CcSEcCtD
Ondansetron—Asthenia—Estropipate—osteoporosis	0.00039	0.0012	CcSEcCtD
Ondansetron—Visual impairment—Estradiol—osteoporosis	0.00039	0.0012	CcSEcCtD
Ondansetron—Chest pain—Zoledronate—osteoporosis	0.00039	0.00119	CcSEcCtD
Ondansetron—Palpitations—Conjugated Estrogens—osteoporosis	0.000389	0.00119	CcSEcCtD
Ondansetron—Anxiety—Zoledronate—osteoporosis	0.000388	0.00119	CcSEcCtD
Ondansetron—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000387	0.00119	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000387	0.00119	CcSEcCtD
Ondansetron—Paraesthesia—Risedronate—osteoporosis	0.000386	0.00118	CcSEcCtD
Ondansetron—Pruritus—Estropipate—osteoporosis	0.000385	0.00118	CcSEcCtD
Ondansetron—Discomfort—Zoledronate—osteoporosis	0.000385	0.00118	CcSEcCtD
Ondansetron—Asthenia—Alendronate—osteoporosis	0.000385	0.00118	CcSEcCtD
Ondansetron—Hypersensitivity—Ibandronate—osteoporosis	0.000384	0.00118	CcSEcCtD
Ondansetron—Cough—Conjugated Estrogens—osteoporosis	0.000384	0.00118	CcSEcCtD
Ondansetron—Dyspnoea—Risedronate—osteoporosis	0.000383	0.00118	CcSEcCtD
Ondansetron—Erythema multiforme—Estradiol—osteoporosis	0.000383	0.00117	CcSEcCtD
Ondansetron—Hypotension—Pamidronate—osteoporosis	0.000382	0.00117	CcSEcCtD
Ondansetron—Convulsion—Conjugated Estrogens—osteoporosis	0.000382	0.00117	CcSEcCtD
Ondansetron—Dry mouth—Zoledronate—osteoporosis	0.000381	0.00117	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000381	0.00117	CcSEcCtD
Ondansetron—Fatigue—Ethinyl Estradiol—osteoporosis	0.00038	0.00117	CcSEcCtD
Ondansetron—Pruritus—Alendronate—osteoporosis	0.000379	0.00116	CcSEcCtD
Ondansetron—Eye disorder—Estradiol—osteoporosis	0.000379	0.00116	CcSEcCtD
Ondansetron—Constipation—Ethinyl Estradiol—osteoporosis	0.000377	0.00116	CcSEcCtD
Ondansetron—Hypersensitivity—Calcitriol—osteoporosis	0.000376	0.00115	CcSEcCtD
Ondansetron—Cardiac disorder—Estradiol—osteoporosis	0.000376	0.00115	CcSEcCtD
Ondansetron—Flushing—Estradiol—osteoporosis	0.000376	0.00115	CcSEcCtD
Ondansetron—Chest pain—Conjugated Estrogens—osteoporosis	0.000375	0.00115	CcSEcCtD
Ondansetron—Asthenia—Ibandronate—osteoporosis	0.000374	0.00115	CcSEcCtD
Ondansetron—Anxiety—Conjugated Estrogens—osteoporosis	0.000374	0.00115	CcSEcCtD
Ondansetron—Anaphylactic shock—Zoledronate—osteoporosis	0.000373	0.00115	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000372	0.00114	CcSEcCtD
Ondansetron—Diarrhoea—Estropipate—osteoporosis	0.000372	0.00114	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Risedronate—osteoporosis	0.000371	0.00114	CcSEcCtD
Ondansetron—Fatigue—Risedronate—osteoporosis	0.000371	0.00114	CcSEcCtD
Ondansetron—Pruritus—Ibandronate—osteoporosis	0.000369	0.00113	CcSEcCtD
Ondansetron—Pain—Risedronate—osteoporosis	0.000368	0.00113	CcSEcCtD
Ondansetron—Constipation—Risedronate—osteoporosis	0.000368	0.00113	CcSEcCtD
Ondansetron—Angiopathy—Estradiol—osteoporosis	0.000367	0.00113	CcSEcCtD
Ondansetron—Shock—Zoledronate—osteoporosis	0.000367	0.00113	CcSEcCtD
Ondansetron—Paraesthesia—Pamidronate—osteoporosis	0.000367	0.00113	CcSEcCtD
Ondansetron—Diarrhoea—Alendronate—osteoporosis	0.000367	0.00112	CcSEcCtD
Ondansetron—Asthenia—Calcitriol—osteoporosis	0.000366	0.00112	CcSEcCtD
Ondansetron—Nervous system disorder—Zoledronate—osteoporosis	0.000366	0.00112	CcSEcCtD
Ondansetron—Immune system disorder—Estradiol—osteoporosis	0.000366	0.00112	CcSEcCtD
Ondansetron—Mediastinal disorder—Estradiol—osteoporosis	0.000365	0.00112	CcSEcCtD
Ondansetron—Dyspnoea—Pamidronate—osteoporosis	0.000364	0.00112	CcSEcCtD
Ondansetron—Tachycardia—Zoledronate—osteoporosis	0.000364	0.00112	CcSEcCtD
Ondansetron—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000363	0.00112	CcSEcCtD
Ondansetron—Chills—Estradiol—osteoporosis	0.000363	0.00111	CcSEcCtD
Ondansetron—Somnolence—Pamidronate—osteoporosis	0.000363	0.00111	CcSEcCtD
Ondansetron—Skin disorder—Zoledronate—osteoporosis	0.000363	0.00111	CcSEcCtD
Ondansetron—Pruritus—Calcitriol—osteoporosis	0.000361	0.00111	CcSEcCtD
Ondansetron—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000361	0.00111	CcSEcCtD
Ondansetron—Diarrhoea—Raloxifene—osteoporosis	0.000361	0.00111	CcSEcCtD
Ondansetron—Dizziness—Estropipate—osteoporosis	0.00036	0.0011	CcSEcCtD
Ondansetron—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00036	0.0011	CcSEcCtD
Ondansetron—Diarrhoea—Ibandronate—osteoporosis	0.000357	0.0011	CcSEcCtD
Ondansetron—Dizziness—Alendronate—osteoporosis	0.000354	0.00109	CcSEcCtD
Ondansetron—Shock—Conjugated Estrogens—osteoporosis	0.000354	0.00109	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000353	0.00108	CcSEcCtD
Ondansetron—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000353	0.00108	CcSEcCtD
Ondansetron—Erythema—Estradiol—osteoporosis	0.000353	0.00108	CcSEcCtD
Ondansetron—Fatigue—Pamidronate—osteoporosis	0.000352	0.00108	CcSEcCtD
Ondansetron—Gastrointestinal pain—Risedronate—osteoporosis	0.000352	0.00108	CcSEcCtD
Ondansetron—Tachycardia—Conjugated Estrogens—osteoporosis	0.000351	0.00108	CcSEcCtD
Ondansetron—Urticaria—Ethinyl Estradiol—osteoporosis	0.00035	0.00107	CcSEcCtD
Ondansetron—Constipation—Pamidronate—osteoporosis	0.00035	0.00107	CcSEcCtD
Ondansetron—Pain—Pamidronate—osteoporosis	0.00035	0.00107	CcSEcCtD
Ondansetron—Diarrhoea—Calcitriol—osteoporosis	0.000349	0.00107	CcSEcCtD
Ondansetron—Skin disorder—Conjugated Estrogens—osteoporosis	0.000349	0.00107	CcSEcCtD
Ondansetron—Hypotension—Zoledronate—osteoporosis	0.000349	0.00107	CcSEcCtD
Ondansetron—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000349	0.00107	CcSEcCtD
Ondansetron—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000349	0.00107	CcSEcCtD
Ondansetron—Dizziness—Raloxifene—osteoporosis	0.000349	0.00107	CcSEcCtD
Ondansetron—Flatulence—Estradiol—osteoporosis	0.000347	0.00107	CcSEcCtD
Ondansetron—Vomiting—Estropipate—osteoporosis	0.000346	0.00106	CcSEcCtD
Ondansetron—Dizziness—Ibandronate—osteoporosis	0.000345	0.00106	CcSEcCtD
Ondansetron—Rash—Estropipate—osteoporosis	0.000343	0.00105	CcSEcCtD
Ondansetron—Dermatitis—Estropipate—osteoporosis	0.000343	0.00105	CcSEcCtD
Ondansetron—Urticaria—Risedronate—osteoporosis	0.000342	0.00105	CcSEcCtD
Ondansetron—Headache—Estropipate—osteoporosis	0.000341	0.00105	CcSEcCtD
Ondansetron—Vomiting—Alendronate—osteoporosis	0.000341	0.00105	CcSEcCtD
Ondansetron—Abdominal pain—Risedronate—osteoporosis	0.00034	0.00104	CcSEcCtD
Ondansetron—Body temperature increased—Risedronate—osteoporosis	0.00034	0.00104	CcSEcCtD
Ondansetron—Rash—Alendronate—osteoporosis	0.000338	0.00104	CcSEcCtD
Ondansetron—Dermatitis—Alendronate—osteoporosis	0.000338	0.00104	CcSEcCtD
Ondansetron—Feeling abnormal—Pamidronate—osteoporosis	0.000337	0.00103	CcSEcCtD
Ondansetron—Hypotension—Conjugated Estrogens—osteoporosis	0.000336	0.00103	CcSEcCtD
Ondansetron—Headache—Alendronate—osteoporosis	0.000336	0.00103	CcSEcCtD
Ondansetron—Paraesthesia—Zoledronate—osteoporosis	0.000335	0.00103	CcSEcCtD
Ondansetron—Vomiting—Raloxifene—osteoporosis	0.000335	0.00103	CcSEcCtD
Ondansetron—Gastrointestinal pain—Pamidronate—osteoporosis	0.000334	0.00103	CcSEcCtD
Ondansetron—Dyspnoea—Zoledronate—osteoporosis	0.000333	0.00102	CcSEcCtD
Ondansetron—Rash—Raloxifene—osteoporosis	0.000332	0.00102	CcSEcCtD
Ondansetron—Dermatitis—Raloxifene—osteoporosis	0.000332	0.00102	CcSEcCtD
Ondansetron—Somnolence—Zoledronate—osteoporosis	0.000332	0.00102	CcSEcCtD
Ondansetron—Vomiting—Ibandronate—osteoporosis	0.000332	0.00102	CcSEcCtD
Ondansetron—Tremor—Estradiol—osteoporosis	0.00033	0.00101	CcSEcCtD
Ondansetron—Headache—Raloxifene—osteoporosis	0.00033	0.00101	CcSEcCtD
Ondansetron—Rash—Ibandronate—osteoporosis	0.000329	0.00101	CcSEcCtD
Ondansetron—Dermatitis—Ibandronate—osteoporosis	0.000329	0.00101	CcSEcCtD
Ondansetron—Ill-defined disorder—Estradiol—osteoporosis	0.000327	0.001	CcSEcCtD
Ondansetron—Headache—Ibandronate—osteoporosis	0.000327	0.001	CcSEcCtD
Ondansetron—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000325	0.000997	CcSEcCtD
Ondansetron—Vomiting—Calcitriol—osteoporosis	0.000325	0.000996	CcSEcCtD
Ondansetron—Agitation—Estradiol—osteoporosis	0.000324	0.000994	CcSEcCtD
Ondansetron—Abdominal pain—Pamidronate—osteoporosis	0.000323	0.000991	CcSEcCtD
Ondansetron—Body temperature increased—Pamidronate—osteoporosis	0.000323	0.000991	CcSEcCtD
Ondansetron—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000323	0.00099	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000322	0.000989	CcSEcCtD
Ondansetron—Angioedema—Estradiol—osteoporosis	0.000322	0.000988	CcSEcCtD
Ondansetron—Rash—Calcitriol—osteoporosis	0.000322	0.000988	CcSEcCtD
Ondansetron—Fatigue—Zoledronate—osteoporosis	0.000322	0.000988	CcSEcCtD
Ondansetron—Dermatitis—Calcitriol—osteoporosis	0.000322	0.000987	CcSEcCtD
Ondansetron—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000321	0.000983	CcSEcCtD
Ondansetron—Headache—Calcitriol—osteoporosis	0.00032	0.000982	CcSEcCtD
Ondansetron—Somnolence—Conjugated Estrogens—osteoporosis	0.00032	0.000981	CcSEcCtD
Ondansetron—Constipation—Zoledronate—osteoporosis	0.000319	0.00098	CcSEcCtD
Ondansetron—Pain—Zoledronate—osteoporosis	0.000319	0.00098	CcSEcCtD
Ondansetron—Malaise—Estradiol—osteoporosis	0.000318	0.000975	CcSEcCtD
Ondansetron—Hypersensitivity—Risedronate—osteoporosis	0.000317	0.000972	CcSEcCtD
Ondansetron—Asthenia—Ethinyl Estradiol—osteoporosis	0.000316	0.000971	CcSEcCtD
Ondansetron—Syncope—Estradiol—osteoporosis	0.000316	0.00097	CcSEcCtD
Ondansetron—Pruritus—Ethinyl Estradiol—osteoporosis	0.000312	0.000957	CcSEcCtD
Ondansetron—Palpitations—Estradiol—osteoporosis	0.000312	0.000956	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00031	0.000952	CcSEcCtD
Ondansetron—Fatigue—Conjugated Estrogens—osteoporosis	0.00031	0.000951	CcSEcCtD
Ondansetron—Loss of consciousness—Estradiol—osteoporosis	0.00031	0.000951	CcSEcCtD
Ondansetron—Asthenia—Risedronate—osteoporosis	0.000309	0.000947	CcSEcCtD
Ondansetron—Feeling abnormal—Zoledronate—osteoporosis	0.000308	0.000944	CcSEcCtD
Ondansetron—Cough—Estradiol—osteoporosis	0.000308	0.000944	CcSEcCtD
Ondansetron—Pain—Conjugated Estrogens—osteoporosis	0.000307	0.000943	CcSEcCtD
Ondansetron—Constipation—Conjugated Estrogens—osteoporosis	0.000307	0.000943	CcSEcCtD
Ondansetron—Gastrointestinal pain—Zoledronate—osteoporosis	0.000305	0.000937	CcSEcCtD
Ondansetron—Pruritus—Risedronate—osteoporosis	0.000304	0.000933	CcSEcCtD
Ondansetron—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000302	0.000926	CcSEcCtD
Ondansetron—Hypersensitivity—Pamidronate—osteoporosis	0.000301	0.000924	CcSEcCtD
Ondansetron—Chest pain—Estradiol—osteoporosis	0.0003	0.000921	CcSEcCtD
Ondansetron—Anxiety—Estradiol—osteoporosis	0.000299	0.000918	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000298	0.000915	CcSEcCtD
Ondansetron—Urticaria—Zoledronate—osteoporosis	0.000297	0.00091	CcSEcCtD
Ondansetron—Discomfort—Estradiol—osteoporosis	0.000297	0.00091	CcSEcCtD
Ondansetron—Abdominal pain—Zoledronate—osteoporosis	0.000295	0.000906	CcSEcCtD
Ondansetron—Body temperature increased—Zoledronate—osteoporosis	0.000295	0.000906	CcSEcCtD
Ondansetron—Diarrhoea—Risedronate—osteoporosis	0.000294	0.000903	CcSEcCtD
Ondansetron—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000294	0.000902	CcSEcCtD
Ondansetron—Dry mouth—Estradiol—osteoporosis	0.000294	0.000901	CcSEcCtD
Ondansetron—Asthenia—Pamidronate—osteoporosis	0.000293	0.0009	CcSEcCtD
Ondansetron—Dizziness—Ethinyl Estradiol—osteoporosis	0.000292	0.000895	CcSEcCtD
Ondansetron—Pruritus—Pamidronate—osteoporosis	0.000289	0.000887	CcSEcCtD
Ondansetron—Anaphylactic shock—Estradiol—osteoporosis	0.000288	0.000883	CcSEcCtD
Ondansetron—Urticaria—Conjugated Estrogens—osteoporosis	0.000286	0.000876	CcSEcCtD
Ondansetron—Dizziness—Risedronate—osteoporosis	0.000284	0.000872	CcSEcCtD
Ondansetron—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000284	0.000872	CcSEcCtD
Ondansetron—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000284	0.000872	CcSEcCtD
Ondansetron—Shock—Estradiol—osteoporosis	0.000283	0.000869	CcSEcCtD
Ondansetron—Nervous system disorder—Estradiol—osteoporosis	0.000282	0.000866	CcSEcCtD
Ondansetron—Tachycardia—Estradiol—osteoporosis	0.000281	0.000862	CcSEcCtD
Ondansetron—Vomiting—Ethinyl Estradiol—osteoporosis	0.00028	0.00086	CcSEcCtD
Ondansetron—Diarrhoea—Pamidronate—osteoporosis	0.00028	0.000858	CcSEcCtD
Ondansetron—Skin disorder—Estradiol—osteoporosis	0.00028	0.000857	CcSEcCtD
Ondansetron—Rash—Ethinyl Estradiol—osteoporosis	0.000278	0.000853	CcSEcCtD
Ondansetron—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000278	0.000852	CcSEcCtD
Ondansetron—Headache—Ethinyl Estradiol—osteoporosis	0.000276	0.000848	CcSEcCtD
Ondansetron—Hypersensitivity—Zoledronate—osteoporosis	0.000275	0.000844	CcSEcCtD
Ondansetron—Vomiting—Risedronate—osteoporosis	0.000273	0.000839	CcSEcCtD
Ondansetron—Rash—Risedronate—osteoporosis	0.000271	0.000832	CcSEcCtD
Ondansetron—Dermatitis—Risedronate—osteoporosis	0.000271	0.000831	CcSEcCtD
Ondansetron—Dizziness—Pamidronate—osteoporosis	0.00027	0.000829	CcSEcCtD
Ondansetron—Headache—Risedronate—osteoporosis	0.000269	0.000826	CcSEcCtD
Ondansetron—Asthenia—Zoledronate—osteoporosis	0.000268	0.000822	CcSEcCtD
Ondansetron—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000265	0.000813	CcSEcCtD
Ondansetron—Pruritus—Zoledronate—osteoporosis	0.000264	0.00081	CcSEcCtD
Ondansetron—Vomiting—Pamidronate—osteoporosis	0.00026	0.000797	CcSEcCtD
Ondansetron—Paraesthesia—Estradiol—osteoporosis	0.000258	0.000793	CcSEcCtD
Ondansetron—Asthenia—Conjugated Estrogens—osteoporosis	0.000258	0.000791	CcSEcCtD
Ondansetron—Rash—Pamidronate—osteoporosis	0.000258	0.000791	CcSEcCtD
Ondansetron—Dermatitis—Pamidronate—osteoporosis	0.000258	0.00079	CcSEcCtD
Ondansetron—Dyspnoea—Estradiol—osteoporosis	0.000257	0.000787	CcSEcCtD
Ondansetron—Headache—Pamidronate—osteoporosis	0.000256	0.000786	CcSEcCtD
Ondansetron—Somnolence—Estradiol—osteoporosis	0.000256	0.000785	CcSEcCtD
Ondansetron—Diarrhoea—Zoledronate—osteoporosis	0.000255	0.000784	CcSEcCtD
Ondansetron—Pruritus—Conjugated Estrogens—osteoporosis	0.000254	0.00078	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Estradiol—osteoporosis	0.000248	0.000762	CcSEcCtD
Ondansetron—Fatigue—Estradiol—osteoporosis	0.000248	0.000761	CcSEcCtD
Ondansetron—Dizziness—Zoledronate—osteoporosis	0.000247	0.000758	CcSEcCtD
Ondansetron—Pain—Estradiol—osteoporosis	0.000246	0.000755	CcSEcCtD
Ondansetron—Constipation—Estradiol—osteoporosis	0.000246	0.000755	CcSEcCtD
Ondansetron—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000246	0.000755	CcSEcCtD
Ondansetron—Dizziness—Conjugated Estrogens—osteoporosis	0.000238	0.000729	CcSEcCtD
Ondansetron—Vomiting—Zoledronate—osteoporosis	0.000237	0.000728	CcSEcCtD
Ondansetron—Feeling abnormal—Estradiol—osteoporosis	0.000237	0.000727	CcSEcCtD
Ondansetron—Rash—Zoledronate—osteoporosis	0.000235	0.000722	CcSEcCtD
Ondansetron—Gastrointestinal pain—Estradiol—osteoporosis	0.000235	0.000722	CcSEcCtD
Ondansetron—Dermatitis—Zoledronate—osteoporosis	0.000235	0.000722	CcSEcCtD
Ondansetron—Headache—Zoledronate—osteoporosis	0.000234	0.000718	CcSEcCtD
Ondansetron—Vomiting—Conjugated Estrogens—osteoporosis	0.000229	0.000701	CcSEcCtD
Ondansetron—Urticaria—Estradiol—osteoporosis	0.000229	0.000701	CcSEcCtD
Ondansetron—Body temperature increased—Estradiol—osteoporosis	0.000227	0.000698	CcSEcCtD
Ondansetron—Abdominal pain—Estradiol—osteoporosis	0.000227	0.000698	CcSEcCtD
Ondansetron—Rash—Conjugated Estrogens—osteoporosis	0.000227	0.000695	CcSEcCtD
Ondansetron—Dermatitis—Conjugated Estrogens—osteoporosis	0.000226	0.000695	CcSEcCtD
Ondansetron—Headache—Conjugated Estrogens—osteoporosis	0.000225	0.000691	CcSEcCtD
Ondansetron—Hypersensitivity—Estradiol—osteoporosis	0.000212	0.00065	CcSEcCtD
Ondansetron—Asthenia—Estradiol—osteoporosis	0.000206	0.000633	CcSEcCtD
Ondansetron—Pruritus—Estradiol—osteoporosis	0.000204	0.000625	CcSEcCtD
Ondansetron—Diarrhoea—Estradiol—osteoporosis	0.000197	0.000604	CcSEcCtD
Ondansetron—Dizziness—Estradiol—osteoporosis	0.00019	0.000584	CcSEcCtD
Ondansetron—Vomiting—Estradiol—osteoporosis	0.000183	0.000561	CcSEcCtD
Ondansetron—Rash—Estradiol—osteoporosis	0.000181	0.000557	CcSEcCtD
Ondansetron—Dermatitis—Estradiol—osteoporosis	0.000181	0.000556	CcSEcCtD
Ondansetron—Headache—Estradiol—osteoporosis	0.00018	0.000553	CcSEcCtD
Ondansetron—CYP2C9—Metabolism—FDPS—osteoporosis	3.56e-05	0.00058	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—ADCY5—osteoporosis	3.54e-05	0.000576	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—POMC—osteoporosis	3.51e-05	0.000571	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NFATC1—osteoporosis	3.51e-05	0.000571	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—IL6—osteoporosis	3.5e-05	0.000569	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—DKK1—osteoporosis	3.48e-05	0.000566	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IRS1—osteoporosis	3.47e-05	0.000565	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CALCA—osteoporosis	3.44e-05	0.00056	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—P4HB—osteoporosis	3.42e-05	0.000556	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PGLS—osteoporosis	3.41e-05	0.000554	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GPD2—osteoporosis	3.41e-05	0.000554	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PGLS—osteoporosis	3.38e-05	0.00055	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GPD2—osteoporosis	3.38e-05	0.00055	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—WNT1—osteoporosis	3.35e-05	0.000546	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—GAPDH—osteoporosis	3.35e-05	0.000545	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—POMC—osteoporosis	3.34e-05	0.000544	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.34e-05	0.000543	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TLN1—osteoporosis	3.32e-05	0.000541	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—P4HB—osteoporosis	3.32e-05	0.00054	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—RAP1A—osteoporosis	3.27e-05	0.000531	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—FGA—osteoporosis	3.26e-05	0.000531	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IL6R—osteoporosis	3.26e-05	0.000531	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PTH—osteoporosis	3.23e-05	0.000525	CbGpPWpGaD
Ondansetron—CYP1A2—Biological oxidations—POMC—osteoporosis	3.23e-05	0.000525	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IGF1—osteoporosis	3.22e-05	0.000523	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—ADCY5—osteoporosis	3.22e-05	0.000523	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—RAP1A—osteoporosis	3.18e-05	0.000516	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CNR2—osteoporosis	3.15e-05	0.000512	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—ADCY5—osteoporosis	3.13e-05	0.000508	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ATIC—osteoporosis	3.12e-05	0.000507	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PNP—osteoporosis	3.12e-05	0.000507	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NFATC1—osteoporosis	3.1e-05	0.000504	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—IDH2—osteoporosis	3.1e-05	0.000503	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ATIC—osteoporosis	3.09e-05	0.000503	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PNP—osteoporosis	3.09e-05	0.000503	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—IDH2—osteoporosis	3.09e-05	0.000502	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—DKK1—osteoporosis	3.07e-05	0.0005	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—FDPS—osteoporosis	3.05e-05	0.000495	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PKM—osteoporosis	3.05e-05	0.000495	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PTHLH—osteoporosis	3.03e-05	0.000493	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—BMP2—osteoporosis	3.03e-05	0.000493	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—FGB—osteoporosis	2.97e-05	0.000483	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—WNT1—osteoporosis	2.96e-05	0.000481	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CYP27A1—osteoporosis	2.91e-05	0.000473	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CYP27A1—osteoporosis	2.9e-05	0.000472	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PGLS—osteoporosis	2.89e-05	0.00047	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GPD2—osteoporosis	2.89e-05	0.00047	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—FGA—osteoporosis	2.88e-05	0.000468	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—P4HB—osteoporosis	2.87e-05	0.000466	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PSMA5—osteoporosis	2.87e-05	0.000466	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PSMA2—osteoporosis	2.87e-05	0.000466	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—ADCY5—osteoporosis	2.84e-05	0.000462	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ACP5—osteoporosis	2.83e-05	0.00046	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ACP5—osteoporosis	2.83e-05	0.000459	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PTH—osteoporosis	2.79e-05	0.000454	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—RAP1A—osteoporosis	2.74e-05	0.000446	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CNR2—osteoporosis	2.72e-05	0.000442	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—ADCY5—osteoporosis	2.7e-05	0.000439	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PTHLH—osteoporosis	2.68e-05	0.000435	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—BMP2—osteoporosis	2.68e-05	0.000435	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NFATC1—osteoporosis	2.67e-05	0.000435	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CALCA—osteoporosis	2.67e-05	0.000434	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—DKK1—osteoporosis	2.65e-05	0.000431	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CA2—osteoporosis	2.65e-05	0.000431	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—OXCT1—osteoporosis	2.65e-05	0.000431	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ATIC—osteoporosis	2.64e-05	0.00043	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PNP—osteoporosis	2.64e-05	0.00043	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—ENO1—osteoporosis	2.64e-05	0.000429	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—TPI1—osteoporosis	2.63e-05	0.000428	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CA2—osteoporosis	2.63e-05	0.000427	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—OXCT1—osteoporosis	2.63e-05	0.000427	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—TPI1—osteoporosis	2.63e-05	0.000427	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—FGB—osteoporosis	2.62e-05	0.000426	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—POMC—osteoporosis	2.6e-05	0.000424	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PSMA2—osteoporosis	2.6e-05	0.000423	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PSMA5—osteoporosis	2.6e-05	0.000423	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—MGLL—osteoporosis	2.58e-05	0.00042	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—MGLL—osteoporosis	2.56e-05	0.000416	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—WNT1—osteoporosis	2.56e-05	0.000416	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PSMA2—osteoporosis	2.53e-05	0.000411	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PSMA5—osteoporosis	2.53e-05	0.000411	CbGpPWpGaD
Ondansetron—CYP3A4—Biological oxidations—POMC—osteoporosis	2.49e-05	0.000405	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—FGA—osteoporosis	2.49e-05	0.000404	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—P4HB—osteoporosis	2.47e-05	0.000402	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—P4HB—osteoporosis	2.47e-05	0.000402	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—IL6—osteoporosis	2.46e-05	0.0004	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—ADCY5—osteoporosis	2.45e-05	0.000398	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GAPDH—osteoporosis	2.43e-05	0.000395	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—KL—osteoporosis	2.43e-05	0.000394	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GAPDH—osteoporosis	2.42e-05	0.000394	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.41e-05	0.000393	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—RAP1A—osteoporosis	2.37e-05	0.000385	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—POMC—osteoporosis	2.37e-05	0.000385	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—RAP1A—osteoporosis	2.36e-05	0.000384	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CALCA—osteoporosis	2.36e-05	0.000383	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PKM—osteoporosis	2.35e-05	0.000382	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—FDPS—osteoporosis	2.35e-05	0.000382	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PTHLH—osteoporosis	2.31e-05	0.000376	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—BMP2—osteoporosis	2.31e-05	0.000376	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—IL6R—osteoporosis	2.31e-05	0.000375	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—POMC—osteoporosis	2.3e-05	0.000374	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—FGB—osteoporosis	2.26e-05	0.000368	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—OXCT1—osteoporosis	2.25e-05	0.000365	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CA2—osteoporosis	2.25e-05	0.000365	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PGLS—osteoporosis	2.23e-05	0.000362	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GPD2—osteoporosis	2.23e-05	0.000362	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—IDH2—osteoporosis	2.2e-05	0.000357	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—MGLL—osteoporosis	2.19e-05	0.000356	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PSMA2—osteoporosis	2.18e-05	0.000355	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PSMA5—osteoporosis	2.18e-05	0.000355	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—IDH2—osteoporosis	2.18e-05	0.000354	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—KL—osteoporosis	2.14e-05	0.000348	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CYP19A1—osteoporosis	2.11e-05	0.000343	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—POMC—osteoporosis	2.09e-05	0.000339	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CYP27A1—osteoporosis	2.07e-05	0.000336	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.06e-05	0.000336	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CYP27A1—osteoporosis	2.05e-05	0.000333	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PNP—osteoporosis	2.04e-05	0.000331	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ATIC—osteoporosis	2.04e-05	0.000331	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—IL6R—osteoporosis	2.04e-05	0.000331	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CALCA—osteoporosis	2.03e-05	0.000331	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ACP5—osteoporosis	2.01e-05	0.000327	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ACP5—osteoporosis	1.99e-05	0.000324	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—POMC—osteoporosis	1.98e-05	0.000323	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.97e-05	0.00032	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—MYC—osteoporosis	1.93e-05	0.000314	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—TGFB1—osteoporosis	1.93e-05	0.000314	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ENO1—osteoporosis	1.91e-05	0.000311	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ENO1—osteoporosis	1.91e-05	0.00031	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—ADCY5—osteoporosis	1.9e-05	0.000309	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PSMA2—osteoporosis	1.88e-05	0.000306	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PSMA5—osteoporosis	1.88e-05	0.000306	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PSMA5—osteoporosis	1.88e-05	0.000306	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PSMA2—osteoporosis	1.88e-05	0.000306	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—TPI1—osteoporosis	1.87e-05	0.000304	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—IDH2—osteoporosis	1.86e-05	0.000303	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—TPI1—osteoporosis	1.85e-05	0.000301	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—KL—osteoporosis	1.85e-05	0.0003	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SPP1—osteoporosis	1.84e-05	0.000299	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—POMC—osteoporosis	1.8e-05	0.000293	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL6R—osteoporosis	1.76e-05	0.000286	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—P4HB—osteoporosis	1.76e-05	0.000286	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.75e-05	0.000285	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—P4HB—osteoporosis	1.74e-05	0.000283	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CA2—osteoporosis	1.73e-05	0.000282	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—OXCT1—osteoporosis	1.73e-05	0.000282	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—ADCY5—osteoporosis	1.72e-05	0.00028	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GAPDH—osteoporosis	1.72e-05	0.00028	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—GPX1—osteoporosis	1.72e-05	0.000279	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GAPDH—osteoporosis	1.71e-05	0.000278	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ACP5—osteoporosis	1.7e-05	0.000277	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—MGLL—osteoporosis	1.69e-05	0.000275	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.68e-05	0.000273	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—RAP1A—osteoporosis	1.68e-05	0.000273	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—ADCY5—osteoporosis	1.68e-05	0.000273	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—RAP1A—osteoporosis	1.66e-05	0.000271	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IRS2—osteoporosis	1.66e-05	0.00027	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—LEP—osteoporosis	1.63e-05	0.000265	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SPP1—osteoporosis	1.62e-05	0.000264	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—MTHFR—osteoporosis	1.59e-05	0.000258	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—TPI1—osteoporosis	1.58e-05	0.000257	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—ESR1—osteoporosis	1.55e-05	0.000253	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CYP19A1—osteoporosis	1.53e-05	0.000249	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.53e-05	0.000248	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—P4HB—osteoporosis	1.49e-05	0.000242	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IRS2—osteoporosis	1.47e-05	0.000239	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GAPDH—osteoporosis	1.46e-05	0.000237	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IL6—osteoporosis	1.45e-05	0.000236	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.45e-05	0.000236	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IRS1—osteoporosis	1.45e-05	0.000236	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.45e-05	0.000235	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—IDH2—osteoporosis	1.44e-05	0.000234	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—LEP—osteoporosis	1.44e-05	0.000233	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—RAP1A—osteoporosis	1.42e-05	0.000231	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.4e-05	0.000228	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—POMC—osteoporosis	1.4e-05	0.000227	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—ESR1—osteoporosis	1.37e-05	0.000223	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL6R—osteoporosis	1.36e-05	0.000222	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ENO1—osteoporosis	1.36e-05	0.000221	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.35e-05	0.00022	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ENO1—osteoporosis	1.35e-05	0.000219	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IGF1—osteoporosis	1.34e-05	0.000219	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PSMA5—osteoporosis	1.34e-05	0.000217	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PSMA2—osteoporosis	1.34e-05	0.000217	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PSMA2—osteoporosis	1.33e-05	0.000216	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PSMA5—osteoporosis	1.33e-05	0.000216	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ACP5—osteoporosis	1.31e-05	0.000214	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IRS1—osteoporosis	1.28e-05	0.000208	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—POMC—osteoporosis	1.27e-05	0.000206	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.27e-05	0.000206	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ADCY5—osteoporosis	1.25e-05	0.000203	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ADCY5—osteoporosis	1.25e-05	0.000203	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GPX1—osteoporosis	1.24e-05	0.000202	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GPX1—osteoporosis	1.24e-05	0.000202	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.24e-05	0.000202	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—LEP—osteoporosis	1.24e-05	0.000202	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—POMC—osteoporosis	1.23e-05	0.000201	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—TPI1—osteoporosis	1.22e-05	0.000199	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL6R—osteoporosis	1.2e-05	0.000196	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IGF1—osteoporosis	1.19e-05	0.000193	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.18e-05	0.000192	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ENO1—osteoporosis	1.15e-05	0.000187	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—MTHFR—osteoporosis	1.15e-05	0.000187	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—P4HB—osteoporosis	1.15e-05	0.000187	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—MTHFR—osteoporosis	1.15e-05	0.000186	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PSMA2—osteoporosis	1.13e-05	0.000184	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PSMA5—osteoporosis	1.13e-05	0.000184	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GAPDH—osteoporosis	1.13e-05	0.000183	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.11e-05	0.00018	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—RAP1A—osteoporosis	1.1e-05	0.000178	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.08e-05	0.000176	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.08e-05	0.000175	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—POMC—osteoporosis	1.06e-05	0.000173	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL6R—osteoporosis	1.04e-05	0.000169	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—IL6—osteoporosis	1.03e-05	0.000167	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IGF1—osteoporosis	1.02e-05	0.000167	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP19A1—osteoporosis	9.19e-06	0.000149	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—POMC—osteoporosis	9.19e-06	0.000149	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—POMC—osteoporosis	9.17e-06	0.000149	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—IL6—osteoporosis	9.07e-06	0.000148	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ENO1—osteoporosis	8.87e-06	0.000144	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ADCY5—osteoporosis	8.86e-06	0.000144	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GPX1—osteoporosis	8.83e-06	0.000144	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ADCY5—osteoporosis	8.79e-06	0.000143	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GPX1—osteoporosis	8.76e-06	0.000142	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PSMA5—osteoporosis	8.74e-06	0.000142	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PSMA2—osteoporosis	8.74e-06	0.000142	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—MTHFR—osteoporosis	8.15e-06	0.000133	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—MTHFR—osteoporosis	8.08e-06	0.000131	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MYC—osteoporosis	8.08e-06	0.000131	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TGFB1—osteoporosis	8.06e-06	0.000131	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL6—osteoporosis	7.83e-06	0.000127	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ADCY5—osteoporosis	7.51e-06	0.000122	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GPX1—osteoporosis	7.48e-06	0.000122	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MYC—osteoporosis	7.13e-06	0.000116	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TGFB1—osteoporosis	7.11e-06	0.000116	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP19A1—osteoporosis	7.09e-06	0.000115	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—MTHFR—osteoporosis	6.91e-06	0.000112	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—POMC—osteoporosis	6.52e-06	0.000106	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—POMC—osteoporosis	6.46e-06	0.000105	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MYC—osteoporosis	6.15e-06	0.0001	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TGFB1—osteoporosis	6.14e-06	9.98e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL6—osteoporosis	6.07e-06	9.87e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ADCY5—osteoporosis	5.8e-06	9.42e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GPX1—osteoporosis	5.78e-06	9.39e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—POMC—osteoporosis	5.52e-06	8.98e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL6—osteoporosis	5.36e-06	8.71e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—MTHFR—osteoporosis	5.33e-06	8.67e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL6—osteoporosis	4.63e-06	7.52e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—POMC—osteoporosis	4.26e-06	6.93e-05	CbGpPWpGaD
